# Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma

> **NCT05892185** · NA · UNKNOWN · sponsor: **Mingche Biotechnology CO., LTD** · enrollment: 20 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DEVICE:** GELA
- **DEVICE:** XEN

## Key facts

- **NCT ID:** NCT05892185
- **Lead sponsor:** Mingche Biotechnology CO., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-31
- **Primary completion:** 2024-01-12
- **Final completion:** 2024-07-19
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05892185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05892185, "Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05892185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*